- Home
- PLRX vs QSI Comparison
PLRX vs QSI Comparison
Compare PLRX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- QSI
- Stock Information
- Founded
- PLRX 2015
- QSI 2013
- Country
- PLRX United States
- QSI United States
- Employees
- PLRX N/A
- QSI N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- PLRX Health Care
- QSI Health Care
- Exchange
- PLRX Nasdaq
- QSI Nasdaq
- Market Cap
- PLRX 77.3M
- QSI 334.9M
- IPO Year
- PLRX 2020
- QSI N/A
- Fundamental
- Price
- PLRX $1.39
- QSI $1.71
- Analyst Decision
- PLRX Hold
- QSI Strong Buy
- Analyst Count
- PLRX 10
- QSI 3
- Target Price
- PLRX $9.79
- QSI $2.38
- AVG Volume (30 Days)
- PLRX 1.7M
- QSI 8.7M
- Earning Date
- PLRX 08-06-2025
- QSI 08-05-2025
- Dividend Yield
- PLRX N/A
- QSI N/A
- EPS Growth
- PLRX N/A
- QSI N/A
- EPS
- PLRX N/A
- QSI N/A
- Revenue
- PLRX N/A
- QSI $3,443,000.00
- Revenue This Year
- PLRX N/A
- QSI $77.57
- Revenue Next Year
- PLRX N/A
- QSI $251.34
- P/E Ratio
- PLRX N/A
- QSI N/A
- Revenue Growth
- PLRX N/A
- QSI 167.94
- 52 Week Low
- PLRX $1.10
- QSI $0.61
- 52 Week High
- PLRX $16.10
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- PLRX 53.02
- QSI 45.67
- Support Level
- PLRX $1.13
- QSI $1.67
- Resistance Level
- PLRX $1.50
- QSI $1.89
- Average True Range (ATR)
- PLRX 0.11
- QSI 0.12
- MACD
- PLRX 0.03
- QSI -0.04
- Stochastic Oscillator
- PLRX 71.23
- QSI 5.88
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.